Kali, Inc. (KALY) Research

Kali, Inc., which conducts business as Kali-Extracts, Inc., focuses its efforts on the research and development of cannabis-based treatments. The company aims to address a variety of medical conditions, including various illnesses, diseases, and the persistent pain that can accompany diverse diagnoses. Its offerings encompass a range of products, including pharmaceutical preparations, cannabis extracts, and general health and wellness items. The entity was formerly identified as VLOV Inc. until it adopted the name Kali, Inc. in February 2016. Kali, Inc. is headquartered in Dallas, Texas.

Market snapshot

Symbol
KALY
Price
$0.00
Day change
0.00%
Market cap
$101.8K
P/E ratio
-8.55x
52-week range
0.00005-0.0001
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Acura Pharmaceuticals, Inc. (ACUR)
  • Amazonas Florestal, Ltd (AZFL)
  • Curative Biosciences, Inc. (CBDX)
  • Cannonau Corp. (CNNC)
  • Filament Health Corp. (FLHLF)
  • G Medical Innovations Holdings Ltd (GMVDF)
  • GeneLink, Inc. (GNLKQ)
  • Wayland Group Corp. (MRRCF)

Open Kali, Inc. (KALY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.